
Otsuka Pharmaceutical
Japan-based a pharmaceutical company.
- Finance
- pharmaceutical
JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 5 % | 16 % | 16 % | 15 % | 4 % | - | 4 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 17 % | 18 % | 21 % | 25 % | 21 % | 20 % | 20 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 8 % | 8 % | 6 % | 15 % | 12 % | 11 % | 12 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 16 % | 16 % | 15 % | 13 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

ACQUISITION by Otsuka Pharmaceutical Dec 2020

ACQUISITION by Otsuka Pharmaceutical Jul 2018

ACQUISITION by Otsuka Pharmaceutical Jul 2018

ACQUISITION by Otsuka Pharmaceutical Aug 2024

ACQUISITION by Otsuka Pharmaceutical Oct 2013

ACQUISITION by Otsuka Pharmaceutical Sep 2023